[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Tuberculosis (TB) Diagnostics Market - Global Outlook and Forecast 2021-2027

January 2021 | 93 pages | ID: T1A6C8C31675EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Tuberculosis (TB) Diagnostics in Global, including the following market information:
Global Tuberculosis (TB) Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Tuberculosis (TB) Diagnostics market was valued at 2592.4 million in 2020 and is projected to reach US$ 3068.7 million by 2027, at a CAGR of 4.3% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tuberculosis (TB) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tuberculosis (TB) Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Tuberculosis (TB) Diagnostics Market Segment Percentages, By Type, 2020 (%)
  • Culture-Based Diagnostics
  • Sputum Smear Microscopy
  • Rapid Molecular Diagnostics
  • Others
China Tuberculosis (TB) Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Tuberculosis (TB) Diagnostics Market Segment Percentages, By Application, 2020 (%)
  • Diagnostic Laboratories
  • Hospitals
  • Others
Global Tuberculosis (TB) Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Tuberculosis (TB) Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Tuberculosis (TB) Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Tuberculosis (TB) Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Danaher
  • Roche
  • Thermo Fisher Scientific
  • BD
  • Abbott
  • Hologic
  • Qiagen
  • BioMerieux
  • Hain Lifescience
  • Oxford Immunotec
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tuberculosis (TB) Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tuberculosis (TB) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Tuberculosis (TB) Diagnostics Market Size: 2021 VS 2027
2.2 Global Tuberculosis (TB) Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tuberculosis (TB) Diagnostics Players in Global Market
3.2 Top Global Tuberculosis (TB) Diagnostics Companies Ranked by Revenue
3.3 Global Tuberculosis (TB) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Tuberculosis (TB) Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Tuberculosis (TB) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tuberculosis (TB) Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Tuberculosis (TB) Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tuberculosis (TB) Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Tuberculosis (TB) Diagnostics Market Size Markets, 2021 & 2027
  4.1.2 Culture-Based Diagnostics
  4.1.3 Sputum Smear Microscopy
  4.1.4 Rapid Molecular Diagnostics
  4.1.5 Others
4.2 By Type - Global Tuberculosis (TB) Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Tuberculosis (TB) Diagnostics Revenue, 2016-2021
  4.2.2 By Type - Global Tuberculosis (TB) Diagnostics Revenue, 2022-2027
  4.2.3 By Type - Global Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tuberculosis (TB) Diagnostics Market Size, 2021 & 2027
  5.1.2 Diagnostic Laboratories
  5.1.3 Hospitals
  5.1.4 Others
5.2 By Application - Global Tuberculosis (TB) Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Tuberculosis (TB) Diagnostics Revenue, 2016-2021
  5.2.2 By Application - Global Tuberculosis (TB) Diagnostics Revenue, 2022-2027
  5.2.3 By Application - Global Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Tuberculosis (TB) Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Tuberculosis (TB) Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Tuberculosis (TB) Diagnostics Revenue, 2016-2021
  6.2.2 By Region - Global Tuberculosis (TB) Diagnostics Revenue, 2022-2027
  6.2.3 By Region - Global Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Tuberculosis (TB) Diagnostics Revenue, 2016-2027
  6.3.2 US Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.3.3 Canada Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.3.4 Mexico Tuberculosis (TB) Diagnostics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Tuberculosis (TB) Diagnostics Revenue, 2016-2027
  6.4.2 Germany Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.4.3 France Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.4.4 U.K. Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.4.5 Italy Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.4.6 Russia Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.4.7 Nordic Countries Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.4.8 Benelux Tuberculosis (TB) Diagnostics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Tuberculosis (TB) Diagnostics Revenue, 2016-2027
  6.5.2 China Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.5.3 Japan Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.5.4 South Korea Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.5.5 Southeast Asia Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.5.6 India Tuberculosis (TB) Diagnostics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Tuberculosis (TB) Diagnostics Revenue, 2016-2027
  6.6.2 Brazil Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.6.3 Argentina Tuberculosis (TB) Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tuberculosis (TB) Diagnostics Revenue, 2016-2027
  6.7.2 Turkey Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.7.3 Israel Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.7.4 Saudi Arabia Tuberculosis (TB) Diagnostics Market Size, 2016-2027
  6.7.5 UAE Tuberculosis (TB) Diagnostics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Danaher
  7.1.1 Danaher Corporate Summary
  7.1.2 Danaher Business Overview
  7.1.3 Danaher Tuberculosis (TB) Diagnostics Major Product Offerings
  7.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.1.5 Danaher Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Tuberculosis (TB) Diagnostics Major Product Offerings
  7.2.4 Roche Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.2.5 Roche Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Major Product Offerings
  7.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.3.5 Thermo Fisher Scientific Key News
7.4 BD
  7.4.1 BD Corporate Summary
  7.4.2 BD Business Overview
  7.4.3 BD Tuberculosis (TB) Diagnostics Major Product Offerings
  7.4.4 BD Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.4.5 BD Key News
7.5 Abbott
  7.5.1 Abbott Corporate Summary
  7.5.2 Abbott Business Overview
  7.5.3 Abbott Tuberculosis (TB) Diagnostics Major Product Offerings
  7.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.5.5 Abbott Key News
7.6 Hologic
  7.6.1 Hologic Corporate Summary
  7.6.2 Hologic Business Overview
  7.6.3 Hologic Tuberculosis (TB) Diagnostics Major Product Offerings
  7.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.6.5 Hologic Key News
7.7 Qiagen
  7.7.1 Qiagen Corporate Summary
  7.7.2 Qiagen Business Overview
  7.7.3 Qiagen Tuberculosis (TB) Diagnostics Major Product Offerings
  7.4.4 Qiagen Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.7.5 Qiagen Key News
7.8 BioMerieux
  7.8.1 BioMerieux Corporate Summary
  7.8.2 BioMerieux Business Overview
  7.8.3 BioMerieux Tuberculosis (TB) Diagnostics Major Product Offerings
  7.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.8.5 BioMerieux Key News
7.9 Hain Lifescience
  7.9.1 Hain Lifescience Corporate Summary
  7.9.2 Hain Lifescience Business Overview
  7.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Major Product Offerings
  7.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.9.5 Hain Lifescience Key News
7.10 Oxford Immunotec
  7.10.1 Oxford Immunotec Corporate Summary
  7.10.2 Oxford Immunotec Business Overview
  7.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Major Product Offerings
  7.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue in Global (2016-2021)
  7.10.5 Oxford Immunotec Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Tuberculosis (TB) Diagnostics Market Opportunities & Trends in Global Market
Table 2. Tuberculosis (TB) Diagnostics Market Drivers in Global Market
Table 3. Tuberculosis (TB) Diagnostics Market Restraints in Global Market
Table 4. Key Players of Tuberculosis (TB) Diagnostics in Global Market
Table 5. Top Tuberculosis (TB) Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Tuberculosis (TB) Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Tuberculosis (TB) Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Tuberculosis (TB) Diagnostics Product Type
Table 9. List of Global Tier 1 Tuberculosis (TB) Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis (TB) Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Tuberculosis (TB) Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Tuberculosis (TB) Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Tuberculosis (TB) Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Tuberculosis (TB) Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Tuberculosis (TB) Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Tuberculosis (TB) Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. Danaher Corporate Summary
Table 31. Danaher Tuberculosis (TB) Diagnostics Product Offerings
Table 32. Danaher Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. Roche Corporate Summary
Table 34. Roche Tuberculosis (TB) Diagnostics Product Offerings
Table 35. Roche Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Offerings
Table 38. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. BD Corporate Summary
Table 40. BD Tuberculosis (TB) Diagnostics Product Offerings
Table 41. BD Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. Abbott Corporate Summary
Table 43. Abbott Tuberculosis (TB) Diagnostics Product Offerings
Table 44. Abbott Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. Hologic Corporate Summary
Table 46. Hologic Tuberculosis (TB) Diagnostics Product Offerings
Table 47. Hologic Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. Qiagen Corporate Summary
Table 49. Qiagen Tuberculosis (TB) Diagnostics Product Offerings
Table 50. Qiagen Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 51. BioMerieux Corporate Summary
Table 52. BioMerieux Tuberculosis (TB) Diagnostics Product Offerings
Table 53. BioMerieux Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 54. Hain Lifescience Corporate Summary
Table 55. Hain Lifescience Tuberculosis (TB) Diagnostics Product Offerings
Table 56. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)
Table 57. Oxford Immunotec Corporate Summary
Table 58. Oxford Immunotec Tuberculosis (TB) Diagnostics Product Offerings
Table 59. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Tuberculosis (TB) Diagnostics Segment by Type
Figure 2. Tuberculosis (TB) Diagnostics Segment by Application
Figure 3. Global Tuberculosis (TB) Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Tuberculosis (TB) Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Tuberculosis (TB) Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2020
Figure 8. By Type - Global Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Tuberculosis (TB) Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. Danaher Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Roche Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BD Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Abbott Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Hologic Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Qiagen Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. BioMerieux Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications